Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Biostatistics Center, George Washington University, Rockville, Maryland.
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):854-861. doi: 10.2215/CJN.14831218. Epub 2019 May 23.
Glomerular hyperfiltration has been considered to be a contributing factor to the development of diabetic kidney disease (DKD). To address this issue, we analyzed GFR follow-up data on participants with type 1 diabetes undergoing I-iothalamate clearance on entry into the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications study.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a cohort study of DCCT participants with type 1 diabetes who underwent an I-iothalamate clearance (iGFR) at DCCT baseline. Presence of hyperfiltration was defined as iGFR levels ≥140 ml/min per 1.73 m, with secondary thresholds of 130 or 150 ml/min per 1.73 m. Cox proportional hazards models assessed the association between the baseline hyperfiltration status and the subsequent risk of reaching an eGFR <60 ml/min per 1.73 m.
Of the 446 participants, 106 (24%) had hyperfiltration (iGFR levels ≥140 ml/min per 1.73 m) at baseline. Over a median follow-up of 28 (interquartile range, 23, 33) years, 53 developed an eGFR <60 ml/min per 1.73 m. The cumulative incidence of eGFR <60 ml/min per 1.73 m at 28 years of follow-up was 11.0% among participants with hyperfiltration at baseline, compared with 12.8% among participants with baseline GFR <140 ml/min per 1.73 m. Hyperfiltration was not significantly associated with subsequent risk of developing an eGFR <60 ml/min per 1.73 m in an unadjusted Cox proportional hazards model (hazard ratio, 0.83; 95% confidence interval, 0.43 to 1.62) nor in an adjusted model (hazard ratio, 0.77; 95% confidence interval, 0.38 to 1.54). Application of alternate thresholds to define hyperfiltration (130 or 150 ml/min per 1.73 m) showed similar findings.
Early hyperfiltration in patients with type 1 diabetes was not associated with a higher long-term risk of decreased GFR. Although glomerular hypertension may be a mechanism of kidney injury in DKD, higher total GFR does not appear to be a risk factor for advanced DKD.
肾小球高滤过被认为是糖尿病肾病(DKD)发展的一个促成因素。为了解决这个问题,我们分析了在进入糖尿病控制和并发症试验(DCCT)/糖尿病干预和并发症的流行病学研究时,1 型糖尿病参与者接受碘海醇清除率时的 GFR 随访数据。
设计、设置、参与者和测量:这是一项对 1 型糖尿病的 DCCT 参与者进行的队列研究,他们在 DCCT 基线时接受了碘海醇清除率(iGFR)检查。高滤过的定义为 iGFR 水平≥140 ml/min/1.73 m,次要阈值为 130 或 150 ml/min/1.73 m。Cox 比例风险模型评估了基线高滤过状态与随后 eGFR<60 ml/min/1.73 m 风险之间的关系。
在 446 名参与者中,106 名(24%)在基线时有高滤过(iGFR 水平≥140 ml/min/1.73 m)。在中位随访 28 年(四分位距,23,33)后,53 名参与者的 eGFR<60 ml/min/1.73 m。在 28 年的随访中,基线时有高滤过的参与者的 eGFR<60 ml/min/1.73 m 的累积发生率为 11.0%,而基线时 GFR<140 ml/min/1.73 m 的参与者的累积发生率为 12.8%。未经调整的 Cox 比例风险模型(风险比,0.83;95%置信区间,0.43 至 1.62)和调整后的模型(风险比,0.77;95%置信区间,0.38 至 1.54)均未显示高滤过与随后发生 eGFR<60 ml/min/1.73 m 的风险显著相关。应用替代阈值(130 或 150 ml/min/1.73 m)定义高滤过也显示出相似的结果。
1 型糖尿病患者早期的高滤过与长期肾小球滤过率下降的风险增加无关。尽管肾小球高血压可能是 DKD 肾损伤的机制,但较高的总肾小球滤过率似乎不是晚期 DKD 的危险因素。